We are live on ! Find out more
MNA

Manning & Napier Advisors Portfolio holdings

AUM $7.8B
1-Year Est. Return 25.03%
This Fund
S&P 500
This Quarter Est. Return
+15.96%
1 Year Est. Return
+25.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.8B
AUM Growth
+$707M
Cap. Flow
-$136M
Cap. Flow %
-1.74%
Top 10 Hldgs %
31.71%
Holding
885
New
270
Increased
236
Reduced
238
Closed
21

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$96.8M
2
TRU icon
TransUnion
TRU
+$88M
3
CDNS icon
Cadence Design Systems
CDNS
+$71.2M
4
SBS icon
Sabesp
SBS
+$70.6M
5
NVDA icon
NVIDIA
NVDA
+$65.9M

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Miscellaneous 18.14%
3 Financials 13.71%
4 Healthcare 12.57%
5 Consumer Discretionary 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAGG icon
326
iShares ESG Aware US Aggregate Bond ETF
EAGG
$5.06B
$187K ﹤0.01%
3,922
+120
+3% +$5.69K
KO icon
327
Coca-Cola
KO
$379B
$184K ﹤0.01%
2,230
-1,449
-39% -$114K
CMDY icon
328
iShares Bloomberg Roll Select Commodity Strategy ETF
CMDY
$678M
$183K ﹤0.01%
3,315
WMG icon
329
Warner Music
WMG
$15.1B
$181K ﹤0.01%
+6,687
New +$199K
OTIS icon
330
Otis Worldwide
OTIS
$27.1B
$176K ﹤0.01%
2,410
+40
+2% +$2.99K
IJH icon
331
iShares Core S&P Mid-Cap ETF
IJH
$126B
$173K ﹤0.01%
2,250
VUG icon
332
Vanguard Morningstar Growth ETF
VUG
$228B
$172K ﹤0.01%
1,992
GE icon
333
GE Aerospace
GE
$350B
$170K ﹤0.01%
454
+368
+428% +$115K
TMO icon
334
Thermo Fisher Scientific
TMO
$227B
$170K ﹤0.01%
335
-1,218
-78% -$585K
LHX icon
335
L3Harris
LHX
$47.8B
$167K ﹤0.01%
576
-20,393
-97% -$6.48M
NSC icon
336
Norfolk Southern
NSC
$74B
$166K ﹤0.01%
523
AMGN icon
337
Amgen
AMGN
$236B
$162K ﹤0.01%
448
+267
+148% +$91.4K
AZN icon
338
AstraZeneca
AZN
$252B
$153K ﹤0.01%
+801
New +$151K
ESGE icon
339
iShares ESG Aware MSCI EM ETF
ESGE
$7.1B
$152K ﹤0.01%
2,783
-248
-8% -$13K
VIG icon
340
Vanguard Dividend Appreciation ETF
VIG
$113B
$149K ﹤0.01%
630
SHW icon
341
Sherwin-Williams
SHW
$81B
$141K ﹤0.01%
410
-169,313
-100% -$54.1M
VFVA icon
342
Vanguard US Value Factor ETF
VFVA
$950M
$140K ﹤0.01%
946
CEFA icon
343
Global X S&P Catholic Values Developed ex-US ETF
CEFA
$63.9M
$138K ﹤0.01%
3,489
TRU icon
344
TransUnion
TRU
$15.3B
$137K ﹤0.01%
1,906
-1,255,451
-100% -$88M
SDY icon
345
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$136K ﹤0.01%
890
GEV icon
346
GE Vernova
GEV
$251B
$136K ﹤0.01%
123
+91
+284% +$92.9K
ESML icon
347
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.88B
$132K ﹤0.01%
2,365
-153
-6% -$7.96K
UNP icon
348
Union Pacific
UNP
$172B
$127K ﹤0.01%
466
+336
+258% +$88.2K
IWR icon
349
iShares Russell Mid-Cap ETF
IWR
$56.9B
$124K ﹤0.01%
1,123
BP icon
350
BP
BP
$113B
$122K ﹤0.01%
3,274
+3,132
+2,206% +$137K

Similar funds

Manning & Napier Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Manning & Napier Advisors held 885 positions worth $7.8B, up 10% from $7.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Manning & Napier Advisors's Q2 2026 filing shows 270 new, 236 increased, 238 reduced and 21 closed positions. Its largest new stake was Tenet Healthcare: 901,645 shares worth $169M. The largest sale was Vertex Pharmaceuticals, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Financials.

  • Manning & Napier Advisors's largest Q2 2026 buy was Tenet Healthcare: 901,645 shares worth $169M.
  • Manning & Napier Advisors added most to Vanguard Intermediate-Term Treasury ETF in Q2 2026, an estimated $157M increase.
  • Manning & Napier Advisors's biggest Q2 2026 reduction was Vertex Pharmaceuticals, cutting an estimated $96.8M.
  • Manning & Napier Advisors fully exited Plains All American Pipeline in Q2 2026, selling an estimated $4.47M.
  • Manning & Napier Advisors's ten largest holdings make up 32% of its $7.8B portfolio in Q2 2026.
  • Manning & Napier Advisors opened 270 new positions and closed 21 in Q2 2026.
  • Manning & Napier Advisors's portfolio value rose 10% quarter-over-quarter to $7.8B.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.